Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)
Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perform COI in the Russian Federation (RF). Aim: The ai...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2017-12-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/9278 |
| _version_ | 1826588044573016064 |
|---|---|
| author | Ivan I. Dedov Marina F. Kalashnikova Dmitriy Y. Belousov Aleksey S. Kolbin Vladimir V. Rafalskiy Aleksey E. Cheberda Mariya A. Kantemirova Vadim D. Zakiev Valentin V. Fadeyev |
| author_facet | Ivan I. Dedov Marina F. Kalashnikova Dmitriy Y. Belousov Aleksey S. Kolbin Vladimir V. Rafalskiy Aleksey E. Cheberda Mariya A. Kantemirova Vadim D. Zakiev Valentin V. Fadeyev |
| author_sort | Ivan I. Dedov |
| collection | DOAJ |
| description | Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perform COI in the Russian Federation (RF). Aim: The aim of the secondary objective FORSIGHT-Т2DM study was to conduct Cost-of-Illness Analysis (COI) of Т2DM in the Russian Federation in relation to taking into consideration the presence of complications and concomitant diseases. Materials and methods: COI of Т2DM was performed using the data obtained in Russian multicenter observational, pharmacoepidemiologic cross-sectional study of diabetes care for assessing routine healthcare pattern of T2DM in the Russian Federation (FORSIGHT-Т2DM). Information for each patient was collected from primary medical records and By asking patients to fill out a questionnaire. Total costs were calculated as the sum of direct medical costs (DCm), direct non-medical costs (DCn) and indirect costs (IC). Results: The final analysis included data from 2014 patients with T2DM residing in 45 cities of RF. Total direct medical costs (DCm) of treating Т2DM and its complications and comorbidities amounted to 105 337 rubles ($2742) per patient per year; direct non-medical costs (DCn) amounted to 24 518 rubles ($638) per patient per year; indirect costs (IC) amounted to 149 754 rubles ($3898) per patient per year. The total cost of T2DM in RF in 2014 year amounted to 279 609 rubles ($7278) per patient. The total cost of T2DM in RF in 2014 amounted to 279 609 rubles per patient. Conclusions: More than half (53,5%) of the total cost of T2DM is the loss of GDP due to patients’ disability. The DCm constitute 37,7% of the total cost of the disease, of which 57% is spent on treatment of T2DM complications and concomitant diseases, while only 10% is spent on glucose-lowering therapies. |
| first_indexed | 2024-03-08T15:20:06Z |
| format | Article |
| id | doaj.art-539c7cdef59a4e00acef6e429a6d993f |
| institution | Directory Open Access Journal |
| issn | 2072-0351 2072-0378 |
| language | English |
| last_indexed | 2025-03-14T16:35:04Z |
| publishDate | 2017-12-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj.art-539c7cdef59a4e00acef6e429a6d993f2025-02-21T09:29:35ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782017-12-0120640341910.14341/DM92788365Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)Ivan I. Dedov0Marina F. Kalashnikova1Dmitriy Y. Belousov2Aleksey S. Kolbin3Vladimir V. Rafalskiy4Aleksey E. Cheberda5Mariya A. Kantemirova6Vadim D. Zakiev7Valentin V. Fadeyev8<p>Endocrinology Research Centre</p><p>Sechenov First Moscow State Medical University</p><p>Center of Pharmacoeconomics and Outcomes Research</p><p>Pavlov First St. Petersburg State Medical University</p><p>Smolensk State Medical University; Immanuel Kant Baltic Federal University</p><p>Center of Pharmacoeconomics and Outcomes Research</p><p>City clinical hospital of S. P. Botkin</p><p>Sechenov First Moscow State Medical University</p><p>Sechenov First Moscow State Medical University</p>Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perform COI in the Russian Federation (RF). Aim: The aim of the secondary objective FORSIGHT-Т2DM study was to conduct Cost-of-Illness Analysis (COI) of Т2DM in the Russian Federation in relation to taking into consideration the presence of complications and concomitant diseases. Materials and methods: COI of Т2DM was performed using the data obtained in Russian multicenter observational, pharmacoepidemiologic cross-sectional study of diabetes care for assessing routine healthcare pattern of T2DM in the Russian Federation (FORSIGHT-Т2DM). Information for each patient was collected from primary medical records and By asking patients to fill out a questionnaire. Total costs were calculated as the sum of direct medical costs (DCm), direct non-medical costs (DCn) and indirect costs (IC). Results: The final analysis included data from 2014 patients with T2DM residing in 45 cities of RF. Total direct medical costs (DCm) of treating Т2DM and its complications and comorbidities amounted to 105 337 rubles ($2742) per patient per year; direct non-medical costs (DCn) amounted to 24 518 rubles ($638) per patient per year; indirect costs (IC) amounted to 149 754 rubles ($3898) per patient per year. The total cost of T2DM in RF in 2014 year amounted to 279 609 rubles ($7278) per patient. The total cost of T2DM in RF in 2014 amounted to 279 609 rubles per patient. Conclusions: More than half (53,5%) of the total cost of T2DM is the loss of GDP due to patients’ disability. The DCm constitute 37,7% of the total cost of the disease, of which 57% is spent on treatment of T2DM complications and concomitant diseases, while only 10% is spent on glucose-lowering therapies.https://www.dia-endojournals.ru/jour/article/view/9278type 2 diabetes mellituspharmacoepidemiologyanalysiscost of illnessdirect medical costsdirect non-medical costsindirect costs |
| spellingShingle | Ivan I. Dedov Marina F. Kalashnikova Dmitriy Y. Belousov Aleksey S. Kolbin Vladimir V. Rafalskiy Aleksey E. Cheberda Mariya A. Kantemirova Vadim D. Zakiev Valentin V. Fadeyev Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM) Сахарный диабет type 2 diabetes mellitus pharmacoepidemiology analysis cost of illness direct medical costs direct non-medical costs indirect costs |
| title | Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM) |
| title_full | Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM) |
| title_fullStr | Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM) |
| title_full_unstemmed | Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM) |
| title_short | Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM) |
| title_sort | cost of illness analysis of type 2 diabetes mellitus in the russian federation results from russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus forsight т2dm |
| topic | type 2 diabetes mellitus pharmacoepidemiology analysis cost of illness direct medical costs direct non-medical costs indirect costs |
| url | https://www.dia-endojournals.ru/jour/article/view/9278 |
| work_keys_str_mv | AT ivanidedov costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT marinafkalashnikova costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT dmitriyybelousov costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT alekseyskolbin costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT vladimirvrafalskiy costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT alekseyecheberda costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT mariyaakantemirova costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT vadimdzakiev costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm AT valentinvfadeyev costofillnessanalysisoftype2diabetesmellitusintherussianfederationresultsfromrussianmulticenterobservationalpharmacoepidemiologicstudyofdiabetescareforpatientswithtype2diabetesmellitusforsightt2dm |